Indian Journal of Clinical Biochemistry

, Volume 21, Issue 2, pp 58–62 | Cite as

Effect of buspirone: An anxiolytic drug on blood glucose in humans

  • S. K. Ojha
  • M. Nandave
  • C. Sharma


The present study investigated the effect of an antianxiety drug, buspirone on blood glucose and plasma insulin level concerning the role of 5-HT1A receptors in blood glucose regulation in healthy humans. Twelve healthy male volunteers were administered single oral doses of buspirone (10 mg) or placebo, in a randomized, crossover way, followed by oral glucose load (75 gm in 200 ml) at reported Tmax i.e. the time of peak plasma concentration of the respective administered drug. The blood samples were collected as predose, postdose and post oral glucose load at 0.5, 1.0, 1.5, 2.0, 2.5 and 3.0 hr to investigate the effect of buspirone or placebo at basal blood glucose and plasma insulin level and after oral glucose load induced (postprandial) blood glucose and plasma insulin level. Blood glucose and plasma insulin concentrations were estimated by glucose hexokinase method and enzyme linked immunosorbent assay (ELISA) method respectively. The concentration of blood glucose was significantly (p<0.05) decreased after oral glucose load following administration of buspirone in comparison with placebo however no significant change was observed in the fasting blood glucose and plasma insulin (fasting and oral glucose load induced) level. In conclusions, the present study findings show that buspirone produced a significant alteration in blood glucose level in healthy humans. In addition, study results also indicate that the involvement of serotonergic (5-HT, receptors) mechanism of blood glucose regulation in humans is different from animals.

Key words

Antianxiety drug Oral glucose load healthy volunteers 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lustman, P.J., Griffith, L.S., Clouse, R.E. and Cryer, P.E. (1986) Psychiatric illness in diabetes mellitus, relationship to symptoms and glucose control. J. Nerve Ment. Dis. 174, 736–742.CrossRefGoogle Scholar
  2. 2.
    Popkin, M.K., Callies, A.L., Lentz, R.D., Colon, E.A. and Sutherland, D.E. (1988) Prevalence of major depression, simple phobia and other psychiatric disorders in patients with longstanding type 1 diabetes mellitus. Arch. Gen. Psychiatry 45, 64–68.PubMedGoogle Scholar
  3. 3.
    Simon, N.M. and Pollack, M.H. (1999) Anxiety disorders, in Conn's current therapy, edited by Rakel, R.E. (W. B. Saunders, Philadelphia), 1126.Google Scholar
  4. 4.
    Foster, D.W. (1998) Diabetes mellitus, in Harrison's Principles of Internal Medicine, edited by Fauci, A.S., Martin, J.B., Braunwald, E., Kasper, D.L., Isselbecher, K.J., Hauser, S.L., Wilson, J.D. and Longo, D.L. McGraw Hill, USA 2060.Google Scholar
  5. 5.
    Colin Dollery. (1999) Buspirone, In therapeutic Drugs 2nd Edn., Churchill Livingston, New York, pp B114-B117.Google Scholar
  6. 6.
    Nonogaki, K. and Iguchi, A. (1997) Role of central neural mechanisms in the regulation of hepatic glucose metabolism. Life Sci. 60, 797–807.PubMedCrossRefGoogle Scholar
  7. 7.
    Smith, S.A., Pogson, C.I., Smith, S.A., Pogson C.L. (1977) Tryptophan and the control of plasma glucose concentrations in the rat. Biochem. J. 168, 495–506.PubMedGoogle Scholar
  8. 8.
    Chaouloff, F. and Jeanrenacid, B. (1987) 5-HT-1A and adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effect of 8-hydroxy-2-(di-n-propylamino) tetraline in the conscious rat. J. Pharmacol. Exp. Ther. 243, 1159–1166.PubMedGoogle Scholar
  9. 9.
    Yamada, J., Sugimoto, Y. and Yoshikawa, T. (1998) p-Chloroamphetamine a serotonin releasing drug, elicited in rats a hyperglycemia initiated by 5-HT1A and 5-HT2B/2C receptors. Eur. J. Pharmacol. 359, 185–190.PubMedCrossRefGoogle Scholar
  10. 10.
    Wozanik, K.M. and Linnoila, M. (1991) Hyperglycemic properties of serotonin receptor antagonists. Life Sci. 49, 101–109.CrossRefGoogle Scholar
  11. 11.
    Bridge, M.W., Marvin, G., Thompson, C.E., Sharma, A., Jones, D.A. and Kendall, M.J. (2001) Quantifying the 5-HT1A agonist action of buspirone in man. Psychopharmacol. 158, 224–227.CrossRefGoogle Scholar
  12. 12.
    Martindale the complete drug reference (1999) 32nd edition edited by Parfitt, K. Pharmaceutical Press, 326.Google Scholar
  13. 13.
    Yamada, J., Sugiomoto, Y., Kimura, I., Wantanabe, Y. and Horisaka, K. (1992) The effect of the serotonin-1A receptors agonist buspirone on the blood glucose and pancreatic hormones in the rats. Jpn. J. Pharmacol. 60, 145–148.PubMedCrossRefGoogle Scholar
  14. 14.
    Chaouloff, F., Baudrie, V. and Laude, D. (1990) Evidences that the 5-HT 1A receptor agonist buspirone and iprapirone activates adrenaline release in the conscious rat. Eur. J. Pharmacol. 177, 107–110.PubMedCrossRefGoogle Scholar
  15. 15.
    Sugimoto, Y., Yamada, J., Kimura, I. and Horisaka, K. (1995) The effects of the serotonin 1A agonist buspirone on tolbutamide-induced hypoglycemia in rats. Biol. Pharm. Bull. 18, 1296–1298.PubMedGoogle Scholar
  16. 16.
    Massari, V., Eschwege, E., Valleron, A.J., Massari, V., Eschwege, E. and Valleron, A.J. (1983) Imprecision of new criteria for the oral glucose tolerance test. Diabetologia 24, 100–106.PubMedCrossRefGoogle Scholar
  17. 17.
    Gammans, R.E., Mayol, R.F. and Labudde, J.A. (1986) Metabolism and disposition of buspirone. Am. J. Med. 80, 41–51.PubMedCrossRefGoogle Scholar
  18. 18.
    Kunst, A., Drager, B. and Ziagenhorn, J. (1983) UV methods with hexokinase and glucose 6-phosphate dehydrogenase, In Methods of Enzymatic Analysis. 163–172.Google Scholar
  19. 19.
    Willein, T., Nicholsan, S. and Casey, C. (1985) A micro enzyme-linked immunosorbent assay for insulin antibodies in serum. J. Immunol. Methods 76, 185–194.CrossRefGoogle Scholar
  20. 20.
    Furman, B.L. (1980) Impairment of glucose tolerance produced by diuretics and other drugs. Pharmacol. Ther. 12, 613–640.CrossRefGoogle Scholar
  21. 21.
    Lundiquist, I., Ahren, B. and Hankson, R. (1989) Monoamines in pancreatic islets of guinea pig, hamster, rat and mouse determined by high performance liquid chromatography. Pancreas 4, 662–667.CrossRefGoogle Scholar
  22. 22.
    Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mytecharane, E.J., Saxena, P.R. and Humphrey, P.R. (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46, 157–203.PubMedGoogle Scholar
  23. 23.
    Furman, B.L. and Wilson, G.A. (1980) Further studies on the effects of 5- hydroxytryptophan on plasma glucose and insulin in the mouse. Diabetologia 19, 386–390.PubMedCrossRefGoogle Scholar
  24. 24.
    Yamada, J., Sugimoto, Y., Kimura, I., Tekeuchi, I. and Horisaka, K. (1989) Serotonin induced hypoglycemia and increased plasma insulin levels in mice. Life Sci. 45, 1931–1936.PubMedCrossRefGoogle Scholar
  25. 25.
    Uvnas-moberg, K., Ahlenius, S., Alstel, P. and Hillegart, V. (1996) Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat. Neuroendocrinol. 63, 269–274.CrossRefGoogle Scholar
  26. 26.
    Dixit, R.K., Puri, J.N., Sharma, M.K., Jain, I.P., Singh, S., Ansari, N.A. and Singh, S.P. (2001) Effect of anxiolytics on blood sugar level in rabbits. Indian J. Exp. Biol. 39, 378–380.PubMedGoogle Scholar
  27. 27.
    Bjorkstrand, E., Ahlenius, U., Smedh, U. and Uvans-Moberg. (1996) The oxytocin receptor antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin inhibits effects of the 5-HT1A receptor agonist 8-OH-DPAT on plasma levels of insulin, cholecystokinin and somatostatin. Regul. Pept. 63, 47–52.PubMedCrossRefGoogle Scholar
  28. 28.
    Breum, L., Bjerre, U., Bak, J.F., Jacobson, S. and Astrup, A. (1995) Long term effects of fluoxetine on glycemic control in obese patients with non-insulin-dependent diabetes mellitus or glucose intolerance: influence on muscle glycogen synthase and insulin receptor kinase activity. Metabolism 44, 1570–1576.PubMedCrossRefGoogle Scholar
  29. 29.
    Martin, F.J., Miguez, J.M., Aldegunde, M. and Atienza, G. (1995) Effect of streptozotocin-induced diabetes mellitus on serotonin measured of peripheral tissues in rats. Life Sci. 56, 51–59.PubMedCrossRefGoogle Scholar

Copyright information

© Association of Clinical BIochemists of India 2006

Authors and Affiliations

  1. 1.Department of PharmacologyAll Indian Institute of Medical SciencesNew Delhi
  2. 2.Clinical Research and Medical ServicesDabur Research Foundation (DRF)GhaziabadIndia

Personalised recommendations